A Randomized, Controlled Trial of Continuous Heparin Infusion to Prevent Asymptomatic Catheter-related Thrombosis at Discharge in Infants After Cardiac Surgery: The CHIP-CRT Trial.
Yuyu TanXin SunJing ZhongYouqun ZouYuan RenYumei LiuLijie ZhaoJian ZhuangSheng WangYunxia SunYifei WangPublished in: Journal of pediatric hematology/oncology (2024)
With the early stop of this trial and limited data, it is difficult to draw a definitive conclusion about the efficacy of UFH on CRT. Meanwhile, considering the data from 6 months follow-up, in this population, asymptomatic CRT might resolve with no intervention.
Keyphrases
- cardiac resynchronization therapy
- study protocol
- phase iii
- electronic health record
- randomized controlled trial
- clinical trial
- phase ii
- big data
- low dose
- pulmonary embolism
- left ventricular
- heart failure
- high throughput
- venous thromboembolism
- squamous cell carcinoma
- circulating tumor cells
- growth factor
- locally advanced
- artificial intelligence
- double blind
- drug induced
- placebo controlled